Click here to view original web page at www.finsmes.com
Cadence Neuroscience , a Redmond, Wash.-based developer of a novel neuromodulation therapy, secured $15m in Series A financing. The round was led by Jazz Venture Partners, with participation from Mayo Clinical Ventures, Mayo Benefactors Innovation Fund, and the Epilepsy Foundation of America (EFA). In conjunction with the funding, John […]